Sign in
Taking people in United StatesNo phase

Following young people with type 2 diabetes or obesity for heart disease

Follows young people with type 2 diabetes or obesity to study heart disease.

Key facts

Who runs it
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Where
Bethesda and Washington D.C., United StatesSee the 2 sites
Trial code
Registry title
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
Status
Recruiting
People taking part
930 people, planned
Started
12 Mar 2025
Expected to end
31 Oct 2033
Type of study
Observational, 3 groups
Record updated
17 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 12 to 25 with type 2 diabetes, with overweight or obesity, or who are lean and healthy. Their biological parents can also join.

Age
12 to 25 years for the young participants; no age limit is given for the biological parents.
Sex
All sexes can join.
Disease stage
Young people with type 2 diabetes (confirmed by blood sugar or HbA1c tests), or with overweight or obesity (prediabetes is allowed), or lean with normal HbA1c (below 5.7 percent).
Earlier treatment
Lean healthy participants cannot take prescription or non-prescription medicines, with some exceptions such as topical medicines, vitamins and hormonal contraceptives. They also cannot have used drugs or supplements that change blood sugar or fat metabolism in the past 2 months.
Biomarker or test result
Type 2 diabetes: fasting blood glucose >= 126 mg/dL (7 mmol/L), or postprandial blood sugar >= 200 mg/dL (11.1 mmol/L), or HbA1c >= 6.5% (48 mmol/mol). Lean participants: HbA1c below 5.7 percent.

Main reasons for not taking part

  • Type 1 diabetes or more than 2 diabetes auto-antibodies
  • Pregnant at the screening visit
  • Serious illness that changes metabolism, such as moderate to severe kidney disease, congenital heart disease, Cushing's syndrome or cancer
  • Clinically significant anemia
  • Unable or unwilling to follow the study procedures

The registry criteria, word for word

Show all 14 criteriaShow less

Who cannot take part

  • Y-T2DM, Y-OW and Y-Lean Participants:; 1a. Type 1 diabetes or the presence of >2 diabetes auto-antibodies (e.g., GAD-65, IA-2 antigen, Zinc transporter 8 autoantibodies)
  • Y-Lean participants:; In addition to the above exclusion criteria, any Y-Lean participant who meets any of the following additional criteria will be excluded from the study:; 2a. Current use of prescription or non-prescription medication. Certain exceptions are permitted, including topical medications, vitamins, and hormonal contraceptives. Other medications may be permitted at the discretion of the investigators; 2b. Recent (past 2 months) use of drugs or supplements that alter glucose or lipid metabolism (e.g., niacin, fish oil, red yeast rice); 2c. History of diabetes or abnormal glucose tolerance; 2d.. Abnormal screening labs, including the following:
  • ALT or AST >2 times the upper limit of normal
  • Low eGFR (<90 mL/min/1.73m\^2)Any other abnormality that, in the opinion of the investigator, will increase risk to the subject from participation, or interfere with interpretation of study data; 2e. Meet lab and medical history criteria for Y-T2DM as described in inclusion criterion 1b above
  • b. Medical, psychiatric or cognitive disorders that will, in the opinion of the investigators, limit the subject s ability to comply with study procedures (specific obesity-related comorbidities are explicitly permitted, including hypertension, hyperlipidemia, obstructive sleep apnea and non-alcoholic steatohepatitis); 1c. Serious medical illnesses or diseases thought to alter metabolism (including moderate to severe renal disease (< 30 mL/min/1.73m\^2), congenital heart disease, Cushing s syndrome, cancer, or other metabolic diseases associated with diabetes or excess weight); 1d. For participants enrolled at the NIH, dietary allergies, intolerances or eating patterns that would preclude them from consuming metabolic meals; 1e. Unwilling to comply with all study procedures or to adhere to Lifestyle Considerations throughout study duration; 1f. Pregnancy at the time of the screening visit; 1g. Clinically significant anemia OR Hematocrit below the lower limit of normal for age and sex cutoffs
  • An individual who meets any of the following criteria for their specific group will be excluded from participation in this study:
  • h. For Y-OW Participants- Meet lab and medical history criteria for Y-T2DM as described in inclusion criterion 1b above
  • Glycosuria
  • Biological Parents; -No Exclusion Criteria

Other criteria

  • INCLUSION CRITERIA:; To be eligible to participate in this study, an individual must meet the following criteria according to their group:; Four categories of participants will be included in this study and the inclusion criteria for each group are given below:
  • Participants with Y-T2DM; 1a.Age 12-25 years; 1b.Type 2 diabetes mellitus as defined by fasting blood glucose >= 126 mg/dL OR postprandial blood sugar >= 200 mg/dL OR Hemoglobin A1c >= 6.5% per American Diabetes Association Criteria and one element from the medical history consistent with ADA or AAP guidelines including: family history of diabetes and obesity, maternal or personal history of gestational diabetes, high-risk race and ethnicity, history of cardiovascular disease, hypertension, dyslipidemia, polycystic ovary syndrome, physical inactivity, other clinical conditions associated with insulin resistance (e.g. severe obesity, acanthosis nigricans, prediabetes), small or large for gestational age birth weight, history of breastfeeding, gestational history of illicit drugs including alcohol, smoking OR documentation of type 2 diabetes diagnosed at <=25 years of age with verified medical history (as above)
  • Youth with overweight/ obesity (Y-OW); 2a. Age 12-25 years; 2b. For participants < 18 years of age, BMI >= 85th percentile (overweight) and >= 95th percentile (obesity) for age and sex OR; 2c. For participants >= 18 years of age, BMI >=25<30 kg/m\^2 (overweight) or >=30 kg/m\^2 (obesity); 2d. Participants with obesity may have a diagnosis of prediabetes, defined as fasting blood glucose 100-125 mg/dL OR postprandial blood sugar 140-199 mg/dL OR HbA1c 5.7-6.4 percent (either during testing at NIH or as previously documented on outside medical record)
  • Healthy control lean participants (Y-Lean); 3a. Age 12-25 years; 3b. For participants < 18 years of age, BMI <= 85th percentile for age and sex OR; 3c. For participants >=18 years of age, BMI 18-24.99 kg/m\^2; 3d. HbA1c <5.7 percent (either during testing at NIH or as previously documented on outside medical record)
  • Biological parents of Y-T2DM, Y-OW and Y-Lean participants; 4a. Biological parent of enrolled Y-T2DM, Y-OW and Y-Lean by self-report

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 25 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Stephanie Chung, M.D.Taking people
  • Children's National Hospital (CNH)Washington D.C., United StatesContact: Doris EstradaTaking people

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

Type 2 diabetes is a disease that affects blood sugar levels. Complications can include heart and blood vessel (vascular) diseases. Rates of type 2 diabetes have tripled in children and young adults over the last 40 years. Vascular diseases are also increasing in young people.

Objective:

To learn more about factors, including type 2 diabetes, that may cause vascular disease in young people.

Eligibility:

People aged 12 to 25 years who (1) have type 2 diabetes; (2) are overweight but not diabetic; (3) or are lean and healthy. Biological parents are also needed.

Design:

Young participants will visit the NIH clinic once a year for up to 25 years. Each visit will take 4 days. Before each visit, participants will wear devices to track their sleep, activity, and blood sugar levels for 7 to 10 days.

At each visit, participants will have tests including:

Samples: They will provide blood, urine, and stool samples.

Heart: They will ride a stationary bike for 6 minutes with stickers applied to their chest.

Scans: They will lie on a bed that slides into a tube; the machine will take pictures of the inside of their body.

Energy: They will wear a hood over their head to measure the air they breathe.

Social stress: They will give a speech for 10 minutes to show their body s response to stress.

Glucose: They will drink a sweet drink to see how their blood sugar changes.

Biological parents will have 1 study visit. They will have blood tests. They will fill in questionnaires about their lifestyle and stress.

...

The 3 groups in the trial

  • Healthy control lean participants (Y-Lean)

    A prospective, observational study design in youth aged 12-25 years to compare Y-T2DM with age and BMI-matched youth with overweight or obesity (Y-OW) and age-matched healthy lean peers (Y-Lean).

  • Y-T2DM

    A prospective, observational study design in youth aged 12-25 years to compare Y-T2DM with age and BMI-matched youth with overweight or obesity (Y-OW) and age-matched healthy lean peers (Y-Lean).

  • Youth with overweight/ obesity (Y-OW

    A prospective, observational study design in youth aged 12-25 years to compare Y-T2DM with age and BMI-matched youth with overweight or obesity (Y-OW) and age-matched healthy lean peers (Y-Lean).

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Youth-onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
Plain-language title
Following young people with type 2 diabetes or obesity for heart diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06730113, who can take part
Record updated
17 September 2026